Xu lab: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Peisheng Xu (talk | contribs) (→News) |
Peisheng Xu (talk | contribs) No edit summary |
||
(17 intermediate revisions by the same user not shown) | |||
Line 9: | Line 9: | ||
== News== | == News== | ||
* '''Dr. Xu''' was promoted to Associate Professor with tenure. Special thanks to all the past and current hard-working group members for their great contributions.(12/18/2016) | |||
* '''Bei''' was named as '''Graduate of the Year''' of the South Carolina College of Pharmacy. Congratulations! (06/07/2016) | |||
* '''Bei''' and '''Huacheng''' received their Ph.D. degree at the 2016 Spring commencement ceremony [http://openwetware.org/wiki/Image:Xu_lab_Bei_and_Huacheng_2016_01.jpg 01] [http://openwetware.org/wiki/Image:Xu_lab_Bei_and_Huacheng_2016_02.jpg 02] [http://openwetware.org/wiki/Image:Xu_lab_Bei_and_Huacheng_2016_03.jpg 03]. '''Congratulations Dr. Cheng and Dr. He!''' (05/07/2016) | |||
*Congratulations to '''Eleni'''! She won the ASPIRE-I (Track II) grant award from The Office of the Vice President for Research of USC. (04/25/2016) | |||
*Congratulations to '''Huacheng'''! He has successfully defended his dissertation. (04/07/2016) | |||
*Congratulations to '''Bei'''! She has successfully defended her dissertation. (04/06/2016) | |||
*"'''A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth'''" , a study collaborated with Dr. Hexin Chen that Eleni and Peisheng participated in as co-authors, is accepted for publication in ''Oncotarget'' (03/03/16) | |||
*Our patent application, '''Preparation of triple responsive nanogel system and its application''', has been approved by the US Patent and Trademark Office. The issued patent number is 9,283,281. (02/24/2016) | |||
*"'''Cancer cell selective-killing polymer/copper combination '''" by Huacheng is accepted for publication in ''Biomaterials Science'' and selected as '''back cover'''. (10/29/2015) | |||
*Our patent application, '''Tetrary gene delivery system for gene therapy and methods of its use''', has been approved by the US Patent and Trademark Office. The issued patent number is 9,168,230. (10/27/2015) | |||
*Our patent application, '''Preparation of nanogel cocktail and its application''', has been approved by the US Patent and Trademark Office. The issued patent number is 9,149,535. (10/06/2015). | |||
*Our patent application, '''Charge reversible polymers''', has been approved by the US Patent and Trademark Office. The issued patent number is 9,145,472. (09/29/2015) | |||
*Congratulations to '''Bei'''! She won the 2015 '''RiteDose Award'''. (08/06/2015) | |||
*"'''Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to NIR Light and Redox Potential as a Theranostic Platform for Cancer Therapy '''" by Bei and Huacheng is accepted for publication in ''Journal of Biomedical Nanotechnology''. (06/14/2015) | |||
* Our patent application, '''Nanoparticles for cytoplasmic drug delivery to cancer cells''', has been approved by the US Patent and Trademark Office. The issued patent number is 8,945,629. (02/03/2015) | * Our patent application, '''Nanoparticles for cytoplasmic drug delivery to cancer cells''', has been approved by the US Patent and Trademark Office. The issued patent number is 8,945,629. (02/03/2015) | ||
*"'''Dual secured nano-melittin for safe and effective eradicating cancer cells'''" by Bei and Bindu is accepted for publication in ''Journal of Materials Chemistry B''. (10/28/ | *"'''Dual secured nano-melittin for safe and effective eradicating cancer cells'''" by Bei and Bindu is accepted for publication in ''Journal of Materials Chemistry B''. (10/28/2014) | ||
*According to Google Scholar, Dr. Xu's publications have been cited '''1000''' times. (10/25/ | *According to Google Scholar, Dr. Xu's publications have been cited '''1000''' times. (10/25/2014) | ||
Line 112: | Line 155: | ||
==Personnel== | ==Personnel== | ||
*'''Dr. Renjith P. Johnson ''' from Pusan National University, Korea, joins the lab on May 4th, 2015 as a post-doctoral associate. Welcome aboard! | |||
*'''Dr. Eleni Markoutsa ''' from the University of Patras, Greece, joins the lab on October 16th, 2014 as a post-doctoral associate. Welcome aboard! | *'''Dr. Eleni Markoutsa ''' from the University of Patras, Greece, joins the lab on October 16th, 2014 as a post-doctoral associate. Welcome aboard! | ||
Line 150: | Line 196: | ||
'''Peisheng Xu''', Ph.D. | '''Peisheng Xu''', Ph.D. | ||
Associate Professor of Pharmaceutics | |||
[https://www.sccp.sc.edu/ddbs_faculty_directory Department of Drug Discovery and Biomedical Sciences] | [https://www.sccp.sc.edu/ddbs_faculty_directory Department of Drug Discovery and Biomedical Sciences] |
Revision as of 16:17, 18 December 2016
Home ; Research ; Lab Members ; Publications ; Contact ; Internal ; Talks ;
Welcome to Xu lab! Graduate Research Assistant position is available for highly self-motivated student. Please contact Dr. Xu (xup@sccp.sc.edu) for detailed information.
News
Personnel
Contact information:Peisheng Xu, Ph.D. Associate Professor of Pharmaceutics Department of Drug Discovery and Biomedical Sciences South Carolina College of Pharmacy
715 Sumter St, 609A Columbia, SC, 29208 Phone: 803-777-0075 Fax: 803-777-8356 xup@sccp.sc.edu |